Neumora Therapeutics Inc
NASDAQ:NMRA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Neumora Therapeutics Inc
NASDAQ:NMRA
|
US |
|
S
|
Shrinkflex (Thailand) PCL
SET:SFT
|
TH |
|
E
|
E79 Gold Mines Ltd
ASX:E79
|
AU |
|
K
|
Kingspan Group PLC
F:KRX
|
IE |
|
Dilip Buildcon Ltd
NSE:DBL
|
IN |
|
Roots Corp
TSX:ROOT
|
CA |
|
Fuller Smith & Turner PLC
LSE:FSTA
|
UK |
|
Queste Communications Ltd
ASX:QUE
|
AU |
Wall St Price Targets
NMRA Price Targets Summary
Neumora Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for NMRA is 6.27 USD with a low forecast of 3.03 USD and a high forecast of 14.7 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NMRA's stock price target?
Price Target
6.27
USD
According to Wall Street analysts, the average 1-year price target for NMRA is 6.27 USD with a low forecast of 3.03 USD and a high forecast of 14.7 USD.